NeuBase Therapeutics, Inc.
NBSE · NASDAQ
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,776 | -$25,409 | -$17,385 | -$26,958 |
| Dep. & Amort. | $1,263 | $403 | $280 | $128 |
| Deferred Tax | $0 | -$985 | $0 | $493 |
| Stock-Based Comp. | $2,898 | $3,696 | $5,195 | $8,959 |
| Change in WC | $177 | $361 | $479 | $623 |
| Other Non-Cash | $427 | $3,061 | $720 | $13,084 |
| Operating Cash Flow | -$29,012 | -$18,874 | -$10,710 | -$2,845 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$472 | -$1,438 | -$717 | -$553 |
| Net Acquisitions | $472 | -$1,100 | $0 | -$133 |
| Inv. Purchases | -$14,987 | -$59,989 | $0 | $0 |
| Inv. Sales/Matur. | $14,987 | $59,963 | $0 | $0 |
| Other Inv. Act. | -$472 | -$0 | -$717 | -$97 |
| Investing Cash Flow | -$472 | -$2,563 | -$717 | -$685 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $42,616 | $33,284 | $13,227 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$257 | $42,338 | $33,105 | $13,595 |
| Financing Cash Flow | -$257 | $42,338 | $33,105 | $13,595 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$29,741 | $20,901 | $21,678 | $10,064 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,893 | $31,992 | $10,314 | $250 |
| End Cash | $23,153 | $52,893 | $31,992 | $10,314 |
| Free Cash Flow | -$29,484 | -$20,312 | -$11,427 | -$3,398 |